Additional file 1: of Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review

Appendix 1. Description of included and excluded interventions for drug safety surveillance. Appendix 2. Glossary of terms. Appendix 3. Medline search strategy. Appendix 4. Sources for grey literature search. Appendix 5. List of included studies. Appendix 6. Social media data processing pipeline. Appendix 7. Pre-existing social media listening platforms for drug safety surveillance. Appendix 8. Utility of social media data for drug safety surveillance. Appendix 9. Pre-processing methods and results. Appendix 10. De-identification methods and results. Appendix 11. De-duplication methods and results. Appendix 12. Concept identification methods and results. Appendix 13. Drug name normalization methods and results. Appendix 14. Medical event normalization methods and results. Appendix 15. Relation extraction methods and results. Appendix 16. Additional processing methods and results. Appendix 17. Utility and challenges with socila media listening for drug safety surveillance. (DOCX 275 kb

Study Flow Diagram.

<p>Breakdown of the number of studies identified in the literature, assessed for eligibility, and finally included in the rapid scoping review.</p

Additional file 1 of Interventions on gender equity in the workplace: a scoping review

Additional file 1: Appendix 1. PRISMA ScR Checklist. Appendix 2. SAGER Guidelines. Appendix 3. SIITHIA Checklist. Appendix 4. GRIPP2 Reporting Checklist. Appendix 5. Database Search Strategies. Appendix 6. Grey Literature Sources. Appendix 7. L1 Screening Form for Titles and Abstracts. Appendix 8. L2 Screening Form for Full-Text Articles. Appendix 9. Data Abstraction Form. Appendix 10. Closely Related but Ultimately Excluded Studies. Appendix 11. Participants Characteristics. Appendix 12. Participants Characteristics. Appendix 13. PROGRESS Plus Table. Appendix 14. Definitions of Gender and Sex. Appendix 15. Intervention Characteristics. Appendix 16. Details of Intervention Outcomes and Results. Appendix 17. Outcomes Examined in Included Studies. Appendix 18. Patient Partner Lay Summary